{
	"slug": "ectopic-methotrexate",
	"title": "Ectopic Pregnancy and Methotrexate",
	"authors": [
		"Michelle Lin, MD"
	],
	"categories": [
		{
			"slug": "obgyn",
			"name": "OBGYN"
		}
	],
	"created": "2011/11/11",
	"updates": null,
	"body": "\n# Methotrexate for Ectopic Pregnancy\n\n## Methotrexate (MTX)\n\n**Background**\n\n- Dihydrofolate reductase inhibitor\n- Overall success rate for treating ectopic pregnancy = 71-94%\n- Success rate of single-dose MTX for beta-hCG >5,000 mIU/mL = 85.7% \n\n**Side Effects**\n\n- Abdominal pain\n- Nausea/vomiting\n- Stomatitis    \n\n## Eligibility / Contraindications for MTX in Ectopic Pregnancy\n\n**Eligibility Criteria: (Need to fulfill all criteria)**\n\n- High clinical suspicion or confirmed ectopic pregnancy\n- Hemodynamically stable\n- Unruptured mass\n- Able to comply with close follow-up\n- Normal creatinine, liver transaminases, WBC, hematocrit, and platelet counts \n\n**Contraindications:**\n\n- Breastfeeding\n- Overt or lab evidence of immunodeficiency\n- Alcoholism, alcoholic or chronic liver disease\n- Preexisting blood dyscrasias or significant anemia \n- Known sensitivity to MTX\n- Active pulmonary disease\n- Peptic ulcer disease\n- Hepatic, renal, or hematologic dysfunction\n- Gestational sac >3.5 cm on U/S (relative contraindication) \n- Embryonic cardiac motion on U/S (relative contraindication) \n\n## Single-Dose Regimen\n\n- Day 1: <span class=\"drug\">Methotrexate</span> 50 mg/m2 IM\n\n**Follow up with obstetrician:**\n\n- Days 4 and 7: Measure beta-hCG\n- Between Days 4 and 7: Check for 15% beta-hCG decrease\n- Measure beta-hCG weekly until non-pregnant level\n- If beta-hCG dose not decrease by >15% as expected, re-dose 50 mg/m2 IM and repeat B-hCG on days 4 and 7 after 2nd dose. \n\n## Alternative Regimens\n\n- **Two-Dose** and **Fixed Multidose** regimens available as proposed by ACOG guidelines - Consider for beta-hCG level >5,000 mIU/mL\n\n## References\n\n- ACOG Practice Bulletin No. 94:Medical management of ectopic pregnancy. Obstet Gynecology. 2008; 111(6):1479-85. [[PubMed](http://www.ncbi.nlm.nih.gov/pubmed/18515537)]\n"
}